about
Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and PraziquantelUniversal Stress Proteins as New Targets for Environmental and Therapeutic Interventions of SchistosomiasisPurinergic signaling in schistosomal infectionStage and tissue expression patterns of Schistosoma mansoni venom allergen-like proteins SmVAL 4, 13, 16 and 24.Advances in the Diagnosis of Human Schistosomiasis.Down Regulation of the TCR Complex CD3ζ-Chain on CD3+ T Cells: A Potential Mechanism for Helminth-Mediated Immune Modulation.Fasciola hepatica vaccine: we may not be there yet but we're on the right roadGene function in schistosomes: recent advances toward a cure.Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model.Assessment of the diagnostic efficacy of enolase as an indication of active infection of Schistosoma japonicum.Evaluation of six novel antigens as potential biomarkers for the early immunodiagnosis of schistosomiasis.Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 PolarizationSchistosoma mansoni Infection of Mice, Rats and Humans Elicits a Strong Antibody Response to a Limited Number of Reduction-Sensitive Epitopes on Five Major Tegumental Membrane Proteins.H+ channels in embryonic Biomphalaria glabrata cell membranes: Putative roles in snail host-schistosome interactionsAnti-Inflammatory Properties of Menthol and Menthone in Schistosoma mansoni Infection.In Vitro Schistosomicidal Activity of Phytol and Tegumental Alterations Induced in Juvenile and Adult Stages of Schistosoma haematobiumDevelopment of a schistosomiasis vaccine.Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.Specific humoral response of hosts with variable schistosomiasis susceptibility.Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline.Defining the Pathways of Urogenital Schistosomiasis-Associated Urothelial Carcinogenesis through Transgenic and Bladder Wall Egg Injection Models.Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.Host immunity, nutrition and coinfection alter longitudinal infection patterns of schistosomes in a free ranging African buffalo population.Evaluating diagnostic indicators of urogenital Schistosoma haematobium infection in young women: A cross sectional study in rural South Africa.Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya.Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33.Prevalence and intensity of Schistosoma haematobium infection among schoolchildren in central Zambia before and after mass treatment with a single dose of praziquantel.Treading the Path towards Genetic Control of Snail Resistance to Schistosome InfectionSchistosoma "Eggs-Iting" the Host: Granuloma Formation and Egg Excretion
P2860
Q27304398-3D20650A-155F-40AE-BAA0-2341595E52F0Q28065987-D815D5AB-14A9-410A-8757-BE9266E0560AQ28073072-B9239840-CF5D-422B-8F85-4C00AAB252A1Q33651570-F87FAE50-4D46-4BB1-A1B8-D3AF1E6FD951Q34487530-1117C865-4E9C-401F-8F2F-3B02C8DEDEDCQ35094584-646CA581-E3EC-4AF5-9916-CDF39B3A83F4Q35195502-47092615-F819-42D1-B6DB-4A3D21BB2391Q35427769-8B110ADF-7641-4B65-BB83-770CB893B880Q35665650-BBB65F97-FA7E-4635-B49E-50FF0C8C96B6Q35792780-CEF5BD15-2A1C-4CA4-A4F2-B2CE9B9E5FE3Q36023336-06C4DCFB-A510-4761-8C9B-FF024C027B70Q36201141-D4B74410-773A-4A4D-8BAE-DC9EEA43770CQ36251172-24208875-2D6C-4C7D-B898-76E656B6CC26Q36314917-2592E7F8-7A20-4247-9344-CEA4A9795123Q37015972-6CCDFB90-D45F-41C4-B2F2-958D09DC8623Q37292213-B762CABB-95FC-41DA-8C1C-AE9A9A2C5A60Q37350747-36BAF5F8-0656-404B-A372-84CC0071E8FEQ38968887-E34E4E28-D8FB-4DF4-AC4B-9D9D30952C4DQ38978103-73B4D22B-86BD-44A8-AB82-6F675FE840D6Q39004171-02FBFA04-ED5B-48BB-BF49-6246E727DE94Q40058661-22DA9AF0-FC8B-4AB5-AB17-DDE33787E40AQ46287356-28FDCBFF-8619-4C94-ADC4-5AE13344AC5AQ46430580-E7084C25-5ACF-4BF0-9E7D-51CA5940B275Q49925138-E923B949-45DF-4DEC-A06D-B49E5C9A016FQ52716945-9D91505D-6EEC-4371-B128-E7C25019EEC1Q54253472-5067DE14-95F2-4982-9584-CB082494DA8BQ55342111-DBE32F0A-6B9F-4C44-8F73-A524C5B68652Q57133713-DFE93FD7-8A82-4458-A95C-F64C39E67FD9Q59127674-AE95F094-B3AD-4279-A32C-B49C222540E1
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunology of human schistosomiasis.
@ast
Immunology of human schistosomiasis.
@en
Immunology of human schistosomiasis.
@nl
type
label
Immunology of human schistosomiasis.
@ast
Immunology of human schistosomiasis.
@en
Immunology of human schistosomiasis.
@nl
prefLabel
Immunology of human schistosomiasis.
@ast
Immunology of human schistosomiasis.
@en
Immunology of human schistosomiasis.
@nl
P2860
P921
P356
P1433
P1476
Immunology of human schistosomiasis.
@en
P2093
P2860
P304
P356
10.1111/PIM.12087
P5008
P577
2014-08-01T00:00:00Z